The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective review of metastatic uveal melanoma (mUM) at NYU Perlmutter Cancer Center (NYU-PCC).
 
Juraj Kavecansky
Honoraria - Oncotarget
 
Paul Finger
Leadership - LV Liberty Vision
Stock and Other Ownership Interests - LV Liberty Vision
Patents, Royalties, Other Intellectual Property - LV Liberty Vision Corporation
Travel, Accommodations, Expenses - LV Liberty Vision
 
Melissa Wilson
Consulting or Advisory Role - Bristol-Myers Squibb
 
Kathleen M. Madden
Employment - Bristol-Myers Squibb; Genentech; Genentech; Genentech; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Merck; Merck; Merck; Novartis; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Novartis; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Merck; Merck; Novartis; Novartis
 
Rajni Kannan
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Merck; Merck; Novartis; Novartis
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Merck; Merck; Merck; Novartis; Novartis; Novartis
 
Anna C. Pavlick
Honoraria - Bristol-Myers Squibb; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis